Table 1.
Summary of results (HS only group)
| No. | Donor | Treatment | Pre-Wt. | Post Wt. | (%) | R.M.S. | Channels | (min) | Mobilized | Fragmented |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 |
HG |
Control |
0.357 |
0.353 |
1 |
+1 |
No |
- |
No |
No |
| 2 |
AH |
Control |
0.346 |
0.333 |
4 |
+0 |
No |
- |
No |
No |
| 3 |
HG |
Control |
0.360 |
0.353 |
2 |
+1 |
No |
- |
No |
No |
| 4 |
AH |
Control |
0.330 |
0.327 |
1 |
+1 |
No |
- |
No |
No |
| 5 |
HG |
Vibrate |
0.287 |
0.231 |
20 |
+5 |
Yes |
15 |
Yes |
No |
| 6 |
AH |
Vibrate |
0.229 |
0.188 |
18 |
+5 |
Yes |
20 |
No |
No |
| 7 |
AH |
Control |
0.280 |
0.282 |
0 |
+1 |
No |
- |
No |
No |
| 8 |
HG |
Vibrate |
0.279 |
0.190 |
32 |
+5 |
Yes |
10 |
Yes |
Yes |
| 9 |
HG |
Control |
0.377 |
0.371 |
2 |
+1 |
No |
- |
No |
No |
| 10 |
AH |
Vibrate |
0.423 |
0.310 |
27 |
+5 |
Yes |
20 |
No |
No |
| 11 |
AH |
Control |
0.290 |
0.285 |
2 |
+1 |
No |
- |
No |
No |
| 12 |
HG |
Vibrate |
0.331 |
0.268 |
19 |
+5 |
Yes |
15 |
No |
No |
| 13 |
AH |
Vibrate |
0.267 |
0.214 |
20 |
+4 |
Yes |
20 |
No |
No |
| 14 |
HG |
Vibrate |
0.311 |
0.246 |
21 |
+5 |
Yes |
20 |
No |
No |
| 15 |
AH |
Control |
0.299 |
0.294 |
2 |
+0 |
No |
- |
No |
No |
| 16 | HG | Vibrate | 0.323 | 0.236 | 27 | +6 | Yes | 20 | No | No |
Results of Percent Clot Dissolution (%), Relative Mixing Score (+ 0 to +7), clot length fluid channel development (Yes or No), time by which clot length fluid channels were first observed (min), clot mobilization (Yes or No) and clot fragmentation (Yes or No) in view of a 20 minute exposure of pulsated HS coordinated with “diastolic” timed LFVP (“Vibrate”) versus pulsated HS alone (“Control”). Donors, AH = Andrew Hoffmann (male), HG=Harjit Gill (female).